Endothelial heat shock response in cerebral ischemia

Histology and Histopathology

Volumn 22, Issue 7-9, 2007, Pages 815-823

  Scumpia, A J ^a   Kafel, J ^a   Hallas, B H ^a   Horowitz, J M ^b   Torres, German ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b MEDAILLE COLLEGE   (United States)

Author keywords

Blood vessels; Heat shock proteins; Hypoxia; Infarct core; Penumbra

Indexed keywords

4 PHENYLBUTYRIC ACID; ADENOVIRUS VECTOR; ALTEPLASE; ANSAMYCIN DERIVATIVE; ANTIDEPRESSANT AGENT; ARIMOCLOMOL; BAG 1 PROTEIN; CARBENOXOLONE; CELASTROL; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HERBACEOUS AGENT; HERPESVIRUS VECTOR; INDOMETACIN; POLYPEPTIDE; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; TAUROURSODEOXYCHOLIC ACID; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CELL ACTIVATION; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DEPRESSION; DISEASE COURSE; DRUG MECHANISM; ENDOTHELIUM CELL; GENE MUTATION; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; HYPOXIA; NERVE CELL; NERVE CELL LESION; NERVE CELL NETWORK; NEUROPATHOLOGY; NONHUMAN; NONVIRAL GENE THERAPY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BRAIN; BRAIN HYPOXIA; DRUG ADMINISTRATION; METABOLISM; PARACRINE SIGNALING; VASCULARIZATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA, BRAIN; NEURONS; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 34248550777     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Allison A.C., Cacabelos R., Lombardi V.R., Alvarez X.A. and Vigo C. (2001). Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341-1357.
2. Boado R.J., Li J.Y., Tsukamto H. and Pardridge W.M. (2003). Hypoxia induces de-stabilization of the LAT1 large neutral amino acid transporter mRNA in brain capillary endothelial cells. J. Neurochem. 85, 1037-1042.
3. Bondy S.C. and Lee D.K. (1993). Oxidative stress induced by glutamate receptor agonists. Brain Res. 610, 229-233.
4. Carmeliet P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
5. Carmellet P. and Tessier-Lavigne M. (2005). Common mechanisms of nerve and blood vessel wiring. Nature 436, 193-200.
6. Cleaver O. and Melton D.A. (2003). Endothelial signaling during development. Nat. Med. 9, 661-668.
7. Cooper J.K., Schilling G., Peters M.F., Herring W.J., Sharp A.H., Kaminsky Z., Masone J., Khan FA., Delanoy M., Borchelt D.R., Dawson V.L., Dawson T.M. and Ross C.A. (1998). Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Gent. 7, 783-790.
8. Curry S.H. (2004). Trials and tribulations in the search for stroke drugs. Preclinica 2, 384-387.
9. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L. and Bates G.P. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
10. Dutcher S.A., Underwood B.D., Walker P.D., Diaz F.G. and Michael D.B. (1998). Patterns of heat-shock protein 70 biosynthesis following human traumatic brain injury. J. Neurotrauma 15, 411-420.
11. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C. Hassani H., Hallberg B., Nordlander M. and Cao Ylhai (2003). Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl. Acad. Sci. USA 100, 6033-6038.
12. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., McCall A., Canal I., Orr H.T., Zoghbi H.Y. and Botas J. (2000). Identification of genes that modify ataxin-1 induced neurodegeneration. Nature 408, 101-106.
13. Giffard R.G. and Yenari M.A. (2004). Many mechanisms for Hsp70 protection from cerebral ischemia. J. Neurosurg. Anesthesiol. 16, 53-61.
14. Hsu M., Sik A., Gallyas F., Horvath Z. and Buzsaki G., (1994). Short-term and long-term changes in the postischemic hippocampus. Ann. NY Acad. Sci. 743, 121-139.
15. Kafel J., Baldinger L., Chabla J.M., Hallas B.H., Horowitz J.M. and Torres G. (2006). Blood content modulates the induction of heat shock proteins in the neurovascular network. Brain Res. Bull. 70, 304-311.
16. Kalmar B., Greensmith L., Malcangio M., McMahon S.B., Csermely P. and Burnstock G. (2003). The effect of treatment with BRX-220, a co-inducer of heat shock proteins, on sensory fibers of the rat following peripheral nerve injury. Exp. Neurol. 184, 636-647.
17. Kazemi-Estfarjani P. and Benzer S. (2000). Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840.
18. Kelly S., Uney J.B. and McCulloch J. (2001). Adenovirus HSP70 gene transfer ameliorates damage following global cerebral ischemia. J. Cereb. Blood Flow Metab. 21, S23.
19. Kelly S., Zhang Z.J., Zhao H., Xu L., Giffard R.G., Sapolsky R.M., Yenari M.A. and Steinberg G.K. (2002). Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann. Neurol. 52, 160-167.
20. Kiang J.G. and Tsokos G.C. (1998). Heat shock protein 70 kDa: molecular biology biochemistry, and physiology. Pharmacol Ther. 80, 183-201.
21. Kieran D., Bernadett K., Dick R.T.J., Riddoch-Contreras J., Burnstock G. and Greensmith L. (2004). Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10, 402-405.
22. Kinouchi H., Sharp F.R., Hill M.P., Koistinaho J., Sagar S.M. and Chan P.H. (1993a). Induction of 70-kDa Heat Shock Protein and hsp70 mRNA following transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 13, 105-115.
23. Kinouchi H., Sharp F.R., Koistinaho J., Hicks K., Kamii H. and Chan P.H. (1993b). Induction of heat shock hsp70 mRNA and HSP70 kDa protein in neurons in the 'penumbra' following focal cerebral ischemia in the rat. Brain Res. 619, 334-338.
24. Kokubo Y., Liu J., Radjev S., Kayama T., Sharp F.R. and Weinstein P.R. (2003). Differential cerebral protein synthesis and heat shock protein 70 expression in the core and penumbra of rat brain after transient focal ischemia. Neurosurgery 53, 186-190.
25. Lee B.S., Chen J., Angelidis C., Jurivich D.A. and Morimoto R. (1995). Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stress-induced cellular damage. Proc. Natl. Acad. Sci. USA 92, 7207-7211.
26. Lee J.E., Yenari M.A., Sun G.H., Xu L., Ernond M.R., Chang D., Steinberg G.K. and Giffard R.G. (2001). Differential neuroprotection from human heat shock protein 70 overexpression in vitro and in vivo models of ischemia and ischemia-like conditions. Exp. Neurol. 170, 129-139.
27. Lindsay K. and Bone I. (2004). Neurology and neurosurgery illustrated. 4th ed. Churchill Livingstone. Edinburgh. pp 246-247.
28. Lubbers N.L., Polakowski J.S., Wegner C.D., Burke S.E., Diaz G.J., Daniell K.M. and Cox B.F. (2002). Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats. Eur. J. Pharmacol. 435, 79-83.
29. MacMillan V. and Siesjo B.K. (1972). Brain energy metabolism in hypoxemia. Scand. J. Clin. Lab. Invest. 30, 127-136.
30. McCall A.L., Van Bueren A.M., Nipper V., Moholt-Siebert M., Downes H. and Lessov N. (1996). Forebrain ischemia increases Glut 1 protein in brain microvessels and parenchyma. J. Cereb. Blood Flow Metab. 16, 69-76.
31. Nagayama S., Jono H., Suzaki H., Sakai K., Tsuruya E., Yamatsu I., Isohama Y., Miyata T. and Kai H. (2001). Carbenoxolone, a new inducer of heat shock protein 70. Life Sci. 69, 2867-2873.
32. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z. and Hotamisligil G.S. (2006). Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140.
33. Ohtsuka K. and Suzuki T. (2000). Roles of molecular chaperones in the nervous system. Brain Res. Bull. 53, 141-146.
34. Pasqualini R. and Ruoslahti E. (1996). Organ targeting in vivo using phage display peptide libraries. Nature 380, 364-366.
35. Perera M.N., Henry M.K., Shuji A., Howells D.W., Romesh M., Rowe C.C. and Donnan G.A. (2006). Inflammation following stroke. J. Clin. Neurosci. 13, 1-8.
36. Pugh C.W. and Ratcliffe P.J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684.
37. Rajdev S. and Sharp F.R. (2000). Stress proteins as molecular makers of neurotoxicity. Toxicol. Pathol. 28, 105-112.
38. Rajagopalan S., Brook R., Rubenfire M., Young E. and Pitt B. (2002). Abnormal brachial artery flow-mediated vasodilatation in young adults with major depression. Am. J. Cardiol. 88, 196-198.
39. Rybakowski J.K., Wykretowicz A., Heymann-Szlachcinska A. and Wysocki H. (2006). Impairment of endothelial function in unipolar and bipolar depression. Biol. Psychiatry. 60, 889-891.
40. Sharp F.R., Massa S.M. and Swanson R.A. (1999). Heat-shock protein protection. Trends Neurosci. 22, 97-99.
41. Sherman M.Y. and Goldberg A.L. (2001). Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron 29, 15-32.
42. Sherwood A., Hinderliter A.L., Watkins L.L., Waugh R.A. and Blumenthal J.A. (2005). Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J. Am. Coll. Cardiol 46, 656-659.
43. Sittler A., Lurz R., Lueder G., Priller J., Lahrach H., Hayer-Hartl M.K., Hartle F.U. and Wanker E.E. (2001). Geldanamycin activates a heat shock response and inhibits huntington aggregation in a cell culture model of Huntington's Disease. Hum. Mol. Genet. 10, 1307-1315.
44. Sweeney M.I., Yager J.Y., Walz W. and Juudink B.H. (1995). Cellular mechanisms involved in brain ischemia. Can. J. Physiol. Pharmacol. 73, 1525-1535.
45. Torres G., Hellas B.H., Lorig E.N., Strauss J. and Horowitz J.M. (2004). Dynamic expression of molecular chaperones in structurally and functionally intact endothelial cell networks. Preclinica 2, 197-203.
46. Tucci M., Hammerman S.I., Furfaro S., Saukonnen J.J., Conca T.J. and Farber H.W. (1997). Distinct effect of hypoxia on endothelial cell proliferation and cycling. Am. J. Physiol. 272, c1700-c1708.
47. Vagnucci A.H. and Li W.W. (2003). Alzheimer's disease and angiogenesis. Lancet 361, 605-608.
48. Warrick J.M., Chan H.Y., Gray-Board G.L., Chai Y., Paulson H.L. and Bonini N.M. (1999). Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23, 425-428.
49. Weis S.M. and Cheresh D.A. (2005). Pathophysiological consequences of VIEGF-induced vascular permeability. Nature 437, 497-504.
50. Wu Z., Guo H., Chow N., Sallstrom J., Bell R.D., Deane R., Brooks A.I., Kanagala S., Rubio A., Sagare A., Liu D., Li F., Armstrong D., Gasiewicz T., Zidovetzki R., Song X., Hofman F. and Zlokovic B.V. (2005). Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med. 9, 959-965.
51. Yenari M.A., Fink S.L., Sun G.H., Chang L.K., Patel M.K., Kunis D.M., Onley D., Ho D.Y., Sapolsky R.M. and Steinberg G.K. (1998). Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44, 584-591.
52. Yenari M.A., Giffard R.G., Sapolsky R.M. and Steinberg G.K. (1999). The neuroprotective potential of heat shock protein 70 (HSP70). Mol. Med. Today 5, 525-531.
53. Yu L., Huang Z., Mariani J., Wang Y. Moskowitz M. and Chen J-F. (2004). Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat. Med. 10, 1081-1087.
54. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., Yeh Y., Chen W-T., Kleinman H.K., Grouzmann E. and Grant D.S. (1998). Neuropeptide Y a novel angiogenic factor from the sympathetic nerves and endothelium. Circulation Res. 83, 187-195.